Robert Jenkins

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Steensma David P; Neiger Jessemy D; Porcher Julie C; Keats J Jonathan; Bergsagel P Leif; Dennis Thomas R; Knudson Ryan A; Jenkins Robert B; Santana-Davila Rafael; Kumar Rajiv; Ketterling Rhett P
Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromes.
Drucker Kristen L; Kitange Gaspar J; Kollmeyer Thomas M; Law Mark E; Passe Sandra; Rynearson Amanda L; Blair Hilary; Soderberg Cheryl L; Morlan Bruce W; Ballman Karla V; Giannini Caterina; Jenkins Robert B
Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19.
Rodriguez Fausto J; Mota Renan A; Scheithauer Bernd W; Giannini Caterina; Blair Hilary; New Kent C; Wu Kevin J; Dickson Dennis W; Jenkins Robert B
Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Robert Jenkins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Steensma David P; Neiger Jessemy D; Porcher Julie C; Keats J Jonathan; Bergsagel P Leif; Dennis Thomas R; Knudson Ryan A; Jenkins Robert B; Santana-Davila Rafael; Kumar Rajiv; Ketterling Rhett P
Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromes.
Cancer research 2009;69(19):7518-23.
2009: Drucker Kristen L; Kitange Gaspar J; Kollmeyer Thomas M; Law Mark E; Passe Sandra; Rynearson Amanda L; Blair Hilary; Soderberg Cheryl L; Morlan Bruce W; Ballman Karla V; Giannini Caterina; Jenkins Robert B
Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19.
Genes, chromosomes & cancer 2009;48(10):854-64.
2009: Rodriguez Fausto J; Mota Renan A; Scheithauer Bernd W; Giannini Caterina; Blair Hilary; New Kent C; Wu Kevin J; Dickson Dennis W; Jenkins Robert B
Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma.
Brain pathology (Zurich, Switzerland) 2009;19(4):623-9.
2009: Cicek Mine S; Slager Susan L; Achenbach Sara J; French Amy J; Blair Hilary E; Fink Stephanie R; Foster Nathan R; Kabat Brian F; Halling Kevin C; Cunningham Julie M; Cerhan James R; Jenkins Robert B; Boardman Lisa A; Petersen Gloria M; Sargent Daniel J; Alberts Steven R; Limburg Paul J; Thibodeau Stephen N
Functional and clinical significance of variants localized to 8q24 in colon cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(9):2492-500.
2009: Sukov William R; Ketterling Rhett P; Lager Donna J; Carlson Austin W; Sinnwell Jason P; Chow George K; Jenkins Robert B; Cheville John C
CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
Human pathology 2009;40(9):1296-303.
2009: Wrensch Margaret; Jenkins Robert B; Chang Jeffrey S; Yeh Ru-Fang; Xiao Yuanyuan; Decker Paul A; Ballman Karla V; Berger Mitchel; Buckner Jan C; Chang Susan; Giannini Caterina; Halder Chandralekha; Kollmeyer Thomas M; Kosel Matthew L; LaChance Daniel H; McCoy Lucie; O'Neill Brian P; Patoka Joe; Pico Alexander R; Prados Michael; Quesenberry Charles; Rice Terri; Rynearson Amanda L; Smirnov Ivan; Tihan Tarik; Wiemels Joe; Yang Ping; Wiencke John K
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
Nature genetics 2009;41(8):905-8.
2009: Wang Xiaoke; Hulshizer Rachael L; Erickson-Johnson Michele R; Flynn Heather C; Jenkins Robert B; Lloyd Ricardo V; Oliveira Andre M
Identification of novel HMGA2 fusion sequences in lipoma: evidence that deletion of let-7 miRNA consensus binding site 1 in the HMGA2 3' UTR is not critical for HMGA2 transcriptional upregulation.
Genes, chromosomes & cancer 2009;48(8):673-8.
2009: Reinholz Monica M; Bruzek Amy K; Visscher Daniel W; Lingle Wilma L; Schroeder Matthew J; Perez Edith A; Jenkins Robert B
Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.
The lancet oncology 2009;10(3):267-77.
2009: Rodriguez Fausto J; Scheithauer Bernd W; Erickson Lori A; Jenkins Robert B; Giannini Caterina
Ectopic low-grade adrenocortical carcinoma in the spinal region: immunohistochemical and molecular cytogenetic study of a pediatric case.
The American journal of surgical pathology 2009;33(1):142-8.
2008: Rodriguez Fausto J; Giannini Caterina; Asmann Yan W; Sharma Mukesh K; Perry Arie; Tibbetts Kathleen M; Jenkins Robert B; Scheithauer Bernd W; Anant Shrikant; Jenkins Sarah; Eberhart Charles G; Sarkaria Jann N; Gutmann David H
Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes.
Journal of neuropathology and experimental neurology 2008;67(12):1194-204.
2008: Brown Paul D; Krishnan Sunil; Sarkaria Jann N; Wu Wenting; Jaeckle Kurt A; Uhm Joon H; Geoffroy Francois J; Arusell Robert; Kitange Gaspar; Jenkins Robert B; Kugler John W; Morton Roscoe F; Rowland Kendrith M; Mischel Paul; Yong William H; Scheithauer Bernd W; Schiff David; Giannini Caterina; Buckner Jan C;
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5603-9.
2008: Rodriguez Fausto J; Scheithauer Bernd W; Giannini Caterina; Bryant Sandra C; Jenkins Robert B
Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.
Cancer 2008;113(10):2779-89.
2008: McCollum Andrea K; TenEyck Cynthia J; Stensgard Bridget; Morlan Bruce W; Ballman Karla V; Jenkins Robert B; Toft David O; Erlichman Charles
P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response.
Cancer research 2008;68(18):7419-27.
2008: Macarenco Ricardo S; Uphoff Timothy S; Gilmer Heather Flynn; Jenkins Robert B; Thibodeau Stephen N; Lewis Jean E; Molina Julian R; Yang Ping; Aubry Marie-Christine
Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(9):1168-75.
2008: Gurel Bora; Iwata Tsuyoshi; Koh Cheryl M; Jenkins Robert B; Lan Fusheng; Van Dang Chi; Hicks Jessica L; Morgan James; Cornish Toby C; Sutcliffe Siobhan; Isaacs William B; Luo Jun; De Marzo Angelo M
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(9):1156-67.
2008: Giannini Caterina; Burger Peter C; Berkey Brian A; Cairncross J Gregory; Jenkins Robert B; Mehta Minesh; Curran Walter J; Aldape Ken
Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.
Brain pathology (Zurich, Switzerland) 2008;18(3):360-9.
2008: Rodriguez Fausto J; Scheithauer Bernd W; Perry Arie; Oliveira Andre M; Jenkins Robert B; Oviedo Angelica; Mork Sverre J; Palmer Cheryl A; Burger Peter C
Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic study.
The American journal of surgical pathology 2008;32(5):699-709.
2008: Gilbert Judith A; Goetz Matthew P; Reynolds Carol A; Ingle James N; Giordano Karin F; Suman Vera J; Blair Hilary E; Jenkins Robert B; Lingle Wilma L; Reinholz Monica M; Adjei Alex A; Ames Matthew M
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy.
Molecular cancer therapeutics 2008;7(4):944-51.
2008: Rodriguez Fausto J; Thibodeau Stephen N; Jenkins Robert B; Schowalter Karen V; Caron Bolette L; O'neill Brian P; James Charles David; Passe Sandra; Slezak Jeff; Giannini Caterina
MGMT immunohistochemical expression and promoter methylation in human glioblastoma.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2008;16(1):59-65.
2008: Nakagawa Tohru; Kollmeyer Thomas M; Morlan Bruce W; Anderson S Keith; Bergstralh Eric J; Davis Brian J; Asmann Yan W; Klee George G; Ballman Karla V; Jenkins Robert B
A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy.
PloS one 2008;3(5):e2318.
2007: Zhang Hongying; Macdonald William D; Erickson-Johnson Michele; Wang Xiaoke; Jenkins Robert B; Oliveira Andre M
Cytogenetic and molecular cytogenetic findings of intimal sarcoma.
Cancer genetics and cytogenetics 2007;179(2):146-9.
2007: Highsmith W Edward; Meyer Kevin J; Marley Victoria M; Jenkins Robert B
Conversion Technology for the separation of maternal and paternal copies of any autosomal chromosome in somatic cell hybrids.
Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.] 2007;Chapter 3():Unit 3.6.
2007: Mahlum Eric; Mandal Deendayal; Halder Chandralekha; Maran Avudaiappan; Yaszemski Michael J; Jenkins Robert B; Bolander Mark E; Sarkar Gobinda
Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cells.
Analytical biochemistry 2007;365(2):215-21.
2007: Macarenco Ricardo S; Erickson-Johnson Michele; Wang Xiaoke; Jenkins Robert B; Nascimento Antonio G; Oliveira Andre M
Cytogenetic and molecular cytogenetic findings in dedifferentiated liposarcoma with neural-like whorling pattern and metaplastic bone formation.
Cancer genetics and cytogenetics 2007;172(2):147-50.
2006: Macarenco Ricardo S; Erickson-Johnson Michele; Wang Xiaoke; Jenkins Robert B; Nascimento Antonio G; Oliveira Andre M
Cytogenetic and molecular genetic findings in dedifferentiated liposarcoma with neural-like whorling pattern and metaplastic bone formation.
Cancer genetics and cytogenetics 2006;171(2):126-9.
2006: Jenkins Robert B; Blair Hilary; Ballman Karla V; Giannini Caterina; Arusell Robert M; Law Mark; Flynn Heather; Passe Sandra; Felten Sara; Brown Paul D; Shaw Edward G; Buckner Jan C
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.
Cancer research 2006;66(20):9852-61.
2006: Perez Edith A; Suman Vera J; Davidson Nancy E; Martino Silvana; Kaufman Peter A; Lingle Wilma L; Flynn Patrick J; Ingle James N; Visscher Daniel; Jenkins Robert B
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3032-8.
2005: Perez Edith A; Suman Vera J; Rowland Kendrith M; Ingle James N; Salim Muhammad; Loprinzi Charles L; Flynn Patrick J; Mailliard James A; Kardinal Carl G; Krook James E; Thrower Abby R; Visscher Daniel W; Jenkins Robert B
Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252.
Clinical breast cancer 2005;6(5):425-32.
2005: Romond Edward H; Perez Edith A; Bryant John; Suman Vera J; Geyer Charles E; Davidson Nancy E; Tan-Chiu Elizabeth; Martino Silvana; Paik Soonmyung; Kaufman Peter A; Swain Sandra M; Pisansky Thomas M; Fehrenbacher Louis; Kutteh Leila A; Vogel Victor G; Visscher Daniel W; Yothers Greg; Jenkins Robert B; Brown Ann M; Dakhil Shaker R; Mamounas Eleftherios P; Lingle Wilma L; Klein Pamela M; Ingle James N; Wolmark Norman
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
The New England journal of medicine 2005;353(16):1673-84.
2005: McDonald J Matthew; See Siew Ju; Tremont Ivo W; Colman Howard; Gilbert Mark R; Groves Morris; Burger Peter C; Louis David N; Giannini Caterina; Fuller Gregory; Passe Sandra; Blair Hilary; Jenkins Robert B; Yang Helen; Ledoux Alicia; Aaron Joann; Tipnis Ulka; Zhang Wei; Hess Kenneth; Aldape Ken
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.
Cancer 2005;104(7):1468-77.
2005: Lewis Jason T; Ketterling Rhett P; Halling Kevin C; Reynolds Carol; Jenkins Robert B; Visscher Daniel W
Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining.
American journal of clinical pathology 2005;124(2):273-81.
2005: Galanis Evanthia; Buckner Jan C; Maurer Matthew J; Kreisberg Jeffrey I; Ballman Karla; Boni J; Peralba Josep M; Jenkins Robert B; Dakhil Shaker R; Morton Roscoe F; Jaeckle Kurt A; Scheithauer Bernd W; Dancey Janet; Hidalgo Manuel; Walsh Daniel J;
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(23):5294-304.
2005: Law Mark E; Templeton Kristen L; Kitange Gaspar; Smith Justin; Misra Anjan; Feuerstein Burt G; Jenkins Robert B
Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines.
Cancer genetics and cytogenetics 2005;160(1):1-14.
2005: Yang Ping; Kollmeyer Thomas M; Buckner Kristin; Bamlet William; Ballman Karla V; Jenkins Robert B
Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas.
Cancer 2005;103(11):2363-72.
2005: Pelloski Christopher E; Mahajan Anita; Maor Moshe; Chang Eric L; Woo Shiao; Gilbert Mark; Colman Howard; Yang Helen; Ledoux Alicia; Blair Hilary; Passe Sandra; Jenkins Robert B; Aldape Kenneth D
YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3326-34.
2005: Kitange Gaspar; Misra Anjan; Law Mark; Passe Sandra; Kollmeyer Thomas M; Maurer Matthew; Ballman Karla; Feuerstein Burt G; Jenkins Robert B
Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.
Genes, chromosomes & cancer 2005;42(1):68-77.
2004: Adem Camilo; Soderberg Cheryl L; Hafner Kari; Reynolds Carol; Slezak Jeffrey M; Sinclair Colleen S; Sellers Thomas A; Schaid Daniel J; Couch Fergus; Hartmann Lynn C; Jenkins Robert B
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.
Genes, chromosomes & cancer 2004;41(1):1-11.
2003: Adem Camilo; Soderberg Cheryl L; Cunningham Julie M; Reynolds Carol; Sebo Thomas J; Thibodeau Stephen N; Hartmann Lynn C; Jenkins Robert B
Microsatellite instability in hereditary and sporadic breast cancers.
International journal of cancer. Journal international du cancer 2003;107(4):580-2.
2003: Kitange Gaspar J; Templeton Kristen L; Jenkins Robert B
Recent advances in the molecular genetics of primary gliomas.
Current opinion in oncology 2003;15(3):197-203.
2003: Adem Camilo; Reynolds Carol; Soderberg Cheryl L; Slezak Jeffrey M; McDonnell Shannon K; Sebo Thomas J; Schaid Daniel J; Myers Jeffrey L; Sellers Thomas A; Hartmann Lynn C; Jenkins Robert B
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Cancer 2003;97(1):1-11.
2002: Burton Eric C; Lamborn Kathleen R; Feuerstein Burt G; Prados Michael; Scott James; Forsyth Peter; Passe Sandra; Jenkins Robert B; Aldape Ken D
Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.
Cancer research 2002;62(21):6205-10.
2002: O'Neill Brian P; Blondal Hannes; Yang Ping; Olafsdottir Gurri H; Sigvaldason H; Jenkins Robert B; Kimmel David W; Scheithauer Bernd W; Rocca Walter A; Bjornsson Johannes; Tulinius Hfran
Risk of cancer among relatives of patients with glioma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(9):921-4.
2002: Hartmann Christian; Johnk Loki; Kitange Gaspar; Wu Yanhong; Ashworth Linda K; Jenkins Robert B; Louis David N
Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19.
Cancer research 2002;62(14):4100-8.
2002: Sinclair Colleen S; Adem Camilo; Naderi Ali; Soderberg Cheryl L; Johnson Michele; Wu Kangjian; Wadum Linda; Couch Vicki L; Sellers Thomas A; Schaid Daniel; Slezak Jeffrey; Fredericksen Zach; Ingle James N; Hartmann Lynn; Jenkins Robert B; Couch Fergus J
TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.
Cancer research 2002;62(13):3587-91.
2002: Kuriyama Hiroko; Lamborn Kathleen R; O'Fallon Judith R; Iturria N; Sebo Thomas; Schaefer Paul L; Scheithauer Bernd W; Buckner Jan C; Kuriyama Nagato; Jenkins Robert B; Israel Mark A
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.
Neuro-oncology 2002;4(3):179-86.
2002: Roche Patrick C; Suman Vera J; Jenkins Robert B; Davidson Nancy E; Martino Silvana; Kaufman Peter A; Addo Ferdinand K; Murphy Bronagh; Ingle James N; Perez Edith A
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831.
Journal of the National Cancer Institute 2002;94(11):855-7.
2002: Tsuchiya Norihiko; Kondo Yasushi; Takahashi Atsushi; Pawar Hemant; Qian Junqi; Sato Kazunari; Lieber Michael M; Jenkins Robert B
Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer.
The American journal of pathology 2002;160(5):1799-806.
2002: Halling Kevin C; King Walter; Sokolova Irina A; Karnes R Jeffrey; Meyer Reid G; Powell Eric L; Sebo Thomas J; Cheville John C; Clayton Amy C; Krajnik Kelly L; Ebert Thomas A; Nelson Robert E; Burkhardt Haleh M; Ramakumar Sanjay; Stewart Christopher S; Pankratz Vernon S; Lieber Michael M; Blute Michael L; Zincke Horst; Seelig Steven A; Jenkins Robert B; O'Kane Dennis J
A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
The Journal of urology 2002;167(5):2001-6.
2002: Hartmann Christian; Johnk Loki; Sasaki Hikaru; Jenkins Robert B; Louis David N
Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas.
Brain pathology (Zurich, Switzerland) 2002;12(2):178-82.
2002: Eley Greg D; Reiter Jill L; Pandita Ajay; Park Soyeon; Jenkins Robert B; Maihle Nita J; James C David
A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma.
Neuro-oncology 2002;4(2):86-94.
2002: Perez Edith A; Roche Patrick C; Jenkins Robert B; Reynolds Carol A; Halling Kevin C; Ingle James N; Wold Lester E
HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization.
Mayo Clinic proceedings. Mayo Clinic 2002;77(2):148-54.
2002: Burton Eric C; Lamborn Kathleen R; Forsyth Peter; Scott James; O'Campo Jason; Uyehara-Lock Jane; Prados Michael; Berger Mitchel; Passe Sandra; Uhm Joon; O'Neill Brian P; Jenkins Robert B; Aldape Ken D
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):180-7.
2002: Qian Junqi; Hirasawa Kiyoshi; Bostwick David G; Bergstralh Erik J; Slezak Jeff M; Anderl Kari L; Borell Thomas J; Lieber Michael M; Jenkins Robert B
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(1):35-44.
2001: Kitange G J; Smith J S; Jenkins R B
Genetic alterations and chemotherapeutic response in human diffuse gliomas.
Expert review of anticancer therapy 2001;1(4):595-605.
2001: Burger P C; Pearl D K; Aldape K; Yates A J; Scheithauer B W; Passe S M; Jenkins R B; James C D
Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme?
Journal of neuropathology and experimental neurology 2001;60(11):1099-104.
2001: Hartmann L C; Sellers T A; Schaid D J; Frank T S; Soderberg C L; Sitta D L; Frost M H; Grant C S; Donohue J H; Woods J E; McDonnell S K; Vockley C W; Deffenbaugh A; Couch F J; Jenkins R B
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
Journal of the National Cancer Institute 2001;93(21):1633-7.
2001: Jenkins R B; Curran W; Scott C B; Cairncross G
Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group.
American journal of clinical oncology 2001;24(5):506-8.
2001: McDonnell S K; Schaid D J; Myers J L; Grant C S; Donohue J H; Woods J E; Frost M H; Johnson J L; Sitta D L; Slezak J M; Crotty T B; Jenkins R B; Sellers T A; Hartmann L C
Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3938-43.
2001: Burger P C; Minn A Y; Smith J S; Borell T J; Jedlicka A E; Huntley B K; Goldthwaite P T; Jenkins R B; Feuerstein B G
Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(9):842-53.
2001: Smith J S; Tachibana I; Passe S M; Huntley B K; Borell T J; Iturria N; O'Fallon J R; Schaefer P L; Scheithauer B W; James C D; Buckner J C; Jenkins R B
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
Journal of the National Cancer Institute 2001;93(16):1246-56.
2001: Nigro J M; Takahashi M A; Ginzinger D G; Law M; Passe S; Jenkins R B; Aldape K
Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay.
The American journal of pathology 2001;158(4):1253-62.
2000: Gilhuis H J; Anderl K L; Boerman R H; Jeuken J M; James C D; Raffel C; Scheithauer B W; Jenkins R B
Comparative genomic hybridization of medulloblastomas and clinical relevance: eleven new cases and a review of the literature.
Clinical neurology and neurosurgery 2000;102(4):203-209.
2000: Halling K C; King W; Sokolova I A; Meyer R G; Burkhardt H M; Halling A C; Cheville J C; Sebo T J; Ramakumar S; Stewart C S; Pankratz S; O'Kane D J; Seelig S A; Lieber M M; Jenkins R B
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.
The Journal of urology 2000;164(5):1768-75.
2000: Smith J S; Tachibana I; Lee H K; Qian J; Pohl U; Mohrenweiser H W; Borell T J; Hosek S M; Soderberg C L; von Deimling A; Perry A; Scheithauer B W; Louis D N; Jenkins R B
Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers.
Genes, chromosomes & cancer 2000;29(1):16-25.
2000: Sokolova I A; Halling K C; Jenkins R B; Burkhardt H M; Meyer R G; Seelig S A; King W
The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.
The Journal of molecular diagnostics : JMD 2000;2(3):116-23.
2000: Smith J S; Wang X Y; Qian J; Hosek S M; Scheithauer B W; Jenkins R B; James C D
Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features.
Journal of neuropathology and experimental neurology 2000;59(6):495-503.
2000: Tachibana I; Smith J S; Sato K; Hosek S M; Kimmel D W; Jenkins R B
Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
American journal of medical genetics 2000;92(2):136-41.
2000: Smith J S; Tachibana I; Pohl U; Lee H K; Thanarajasingam U; Portier B P; Ueki K; Ramaswamy S; Billings S J; Mohrenweiser H W; Louis D N; Jenkins R B
A transcript map of the chromosome 19q-arm glioma tumor suppressor region.
Genomics 2000;64(1):44-50.
2000: Bible K C; Boerner S A; Kirkland K; Anderl K L; Bartelt D; Svingen P A; Kottke T J; Lee Y K; Eckdahl S; Stalboerger P G; Jenkins R B; Kaufmann S H
Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):661-70.
2000: Smith J S; Perry A; Borell T J; Lee H K; O'Fallon J; Hosek S M; Kimmel D; Yates A; Burger P C; Scheithauer B W; Jenkins R B
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):636-45.
2000: Smith J S; Jenkins R B
Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications.
Frontiers in bioscience : a journal and virtual library 2000;5():D213-31.
2000: Pohl U; Smith J S; Tachibana I; Ueki K; Lee H K; Ramaswamy S; Wu Q; Mohrenweiser H W; Jenkins R B; Louis D N
EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins.
Genomics 2000;63(2):255-62.
1999: Raffel C; Frederick L; O'Fallon J R; Atherton-Skaff P; Perry A; Jenkins R B; James C D
Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4085-90.
1999: Perry A; Anderl K; Borell T J; Kimmel D W; Wang C H; O'Fallon J R; Feuerstein B G; Scheithauer B W; Jenkins R B
Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas.
American journal of clinical pathology 1999;112(6):801-9.
1999: Peters N; Smith J S; Tachibana I; Lee H K; Pohl U; Portier B P; Louis D N; Jenkins R B
The human glia maturation factor-gamma gene: genomic structure and mutation analysis in gliomas with chromosome 19q loss.
Neurogenetics 1999;2(3):163-6.
1999: Sato K; Qian J; Slezak J M; Lieber M M; Bostwick D G; Bergstralh E J; Jenkins R B
Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma.
Journal of the National Cancer Institute 1999;91(18):1574-80.
1999: James C D; Galanis E; Frederick L; Kimmel D W; Cunningham J M; Atherton-Skaff P J; O'Fallon J R; Jenkins R B; Buckner J C; Hunter S B; Olson J J; Scheithauer B W
Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.
International journal of oncology 1999;15(3):547-53.
1999: Perry A; Jenkins R B; O'Fallon J R; Schaefer P L; Kimmel D W; Mahoney M R; Scheithauer B W; Smith S M; Hill E M; Sebo T J; Levitt R; Krook J; Tschetter L K; Morton R F; Buckner J C
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression.
Cancer 1999;86(4):672-83.
1999: Smith J S; Alderete B; Minn Y; Borell T J; Perry A; Mohapatra G; Hosek S M; Kimmel D; O'Fallon J; Yates A; Feuerstein B G; Burger P C; Scheithauer B W; Jenkins R B
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
Oncogene 1999;18(28):4144-52.
1999: Smith J S; Tachibana I; Allen C; Chiappa S A; Lee H K; McIver B; Jenkins R B; Raffel C
Cloning of a human ortholog (RPH3AL) of (RNO)Rph3al from a candidate 17p13.3 medulloblastoma tumor suppressor locus.
Genomics 1999;59(1):97-101.
1999: Yokomizo A; Mai M; Bostwick D G; Tindall D J; Qian J; Cheng L; Jenkins R B; Smith D I; Liu W
Mutation and expression analysis of the p73 gene in prostate cancer.
The Prostate 1999;39(2):94-100.
1999: Villeneuve J B; Silverman M B; Alderete B; Cliby W A; Li H; Croghan G A; Podratz K C; Jenkins R B
Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer.
Genes, chromosomes & cancer 1999;25(1):65-9.
1999: Couch F J; Wang X Y; Wu G J; Qian J; Jenkins R B; James C D
Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.
Cancer research 1999;59(7):1408-11.
1999: Hartmann L C; Schaid D J; Woods J E; Crotty T P; Myers J L; Arnold P G; Petty P M; Sellers T A; Johnson J L; McDonnell S K; Frost M H; Jenkins R B
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
The New England journal of medicine 1999;340(2):77-84.
1999: Qian J; Jenkins R B; Bostwick D G
Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.
European urology 1999;35(5-6):479-83.
1998: Bostwick D G; Shan A; Qian J; Darson M; Maihle N J; Jenkins R B; Cheng L
Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.
Cancer 1998;83(9):1995-2002.
1998: Qian J; Jenkins R B; Bostwick D G
Determination of gene and chromosome dosage in prostatic intraepithelial neoplasia and carcinoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1998;20(5):373-80.
1998: Galanis E; Buckner J C; Dinapoli R P; Scheithauer B W; Jenkins R B; Wang C H; O'Fallon J R; Farr G
Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Journal of neurosurgery 1998;89(3):425-30.
1998: Yokomizo A; Tindall D J; Hartmann L; Jenkins R B; Smith D I; Liu W
Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
International journal of oncology 1998;13(1):101-5.
1998: Bahuau M; Vidaud D; Jenkins R B; Bièche I; Kimmel D W; Assouline B; Smith J S; Alderete B; Cayuela J M; Harpey J P; Caille B; Vidaud M
Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
Cancer research 1998;58(11):2298-303.
1998: Huang H; Qian C; Jenkins R B; Smith D I
Fish mapping of YAC clones at human chromosomal band 7q31.2: identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer.
Genes, chromosomes & cancer 1998;21(2):152-9.
1998: Jenkins R B; Qian J; Lee H K; Huang H; Hirasawa K; Bostwick D G; Proffitt J; Wilber K; Lieber M M; Liu W; Smith D I
A molecular cytogenetic analysis of 7q31 in prostate cancer.
Cancer research 1998;58(4):759-66.
1997: Liu W; James C D; Frederick L; Alderete B E; Jenkins R B
PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
Cancer research 1997;57(23):5254-7.
1997: Qian J; Jenkins R B; Bostwick D G
Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(11):1113-9.
1997: Perry A; Nobori T; Ru N; Anderl K; Borell T J; Mohapatra G; Feuerstein B G; Jenkins R B; Carson D A
Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR.
Journal of neuropathology and experimental neurology 1997;56(9):999-1008.
1997: Brown J A; Anderl K L; Borell T J; Qian J; Bostwick D G; Jenkins R B
Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.
The Journal of urology 1997;158(2):370-4.
1997: Tefferi A; Bartholmai B J; Witzig T E; Jenkins R B; Li C Y; Hanson C A; Mesa R A; Phyliky R L
Clinical correlations of immunophenotypic variations and the presence of trisomy 12 in B-cell chronic lymphocytic leukemia.
Cancer genetics and cytogenetics 1997;95(2):173-7.
1997: Raffel C; Jenkins R B; Frederick L; Hebrink D; Alderete B; Fults D W; James C D
Sporadic medulloblastomas contain PTCH mutations.
Cancer research 1997;57(5):842-5.
1997: Giannini C; Scheithauer B W; Jenkins R B; Erlandson R A; Perry A; Borell T J; Hoda R S; Woodruff J M
Soft-tissue perineurioma. Evidence for an abnormality of chromosome 22, criteria for diagnosis, and review of the literature.
The American journal of surgical pathology 1997;21(2):164-73.
1997: Jenkins R B; Qian J; Lieber M M; Bostwick D G
Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Cancer research 1997;57(3):524-31.
1997: Cunningham J M; Kimmel D W; Scheithauer B W; O'Fallon J R; Novotny P J; Jenkins R B
Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.
Journal of neurosurgery 1997;86(1):121-30.
1997: Gburek B M; Kollmorgen T A; Qian J; D'Souza-Gburek S M; Lieber M M; Jenkins R B
Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.
The Journal of urology 1997;157(1):223-7.
1996: Schad C R; Kuffel D G; Wyatt W A; Zinsmeister A R; Jenkins R B; Dewald G W; Jalal S M
Application of fluorescent in situ hybridization with X and Y chromosome specific probes to buccal smear analysis.
American journal of medical genetics 1996;66(2):187-92.
1996: Lim P C; Tester D; Cliby W; Ziesmer S C; Roche P C; Hartmann L; Thibodeau S N; Podratz K C; Jenkins R B
Absence of mutations in DNA mismatch repair genes in sporadic endometrial tumors with microsatellite instability.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(11):1907-11.
1996: Qian J; Bostwick D G; Takahashi S; Borell T J; Brown J A; Lieber M M; Jenkins R B
Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens.
The American journal of pathology 1996;149(4):1193-9.
1996: Stratakis C A; Jenkins R B; Pras E; Mitsiadis C S; Raff S B; Stalboerger P G; Tsigos C; Carney J A; Chrousos G P
Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex).
The Journal of clinical endocrinology and metabolism 1996;81(10):3607-14.
1996: Cunningham J M; Shan A; Wick M J; McDonnell S K; Schaid D J; Tester D J; Qian J; Takahashi S; Jenkins R B; Bostwick D G; Thibodeau S N
Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.
Cancer research 1996;56(19):4475-82.
1996: Boerman R H; Anderl K; Herath J; Borell T; Johnson N; Schaeffer-Klein J; Kirchhof A; Raap A K; Scheithauer B W; Jenkins R B
The glial and mesenchymal elements of gliosarcomas share similar genetic alterations.
Journal of neuropathology and experimental neurology 1996;55(9):973-81.
1996: Brown J A; Takahashi S; Alcaraz A; Borell T J; Anderl K L; Qian J; Persons D L; Bostwick D G; Lieber M M; Jenkins R B
Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.
The Journal of urology 1996;156(1):31-5.
1996: Perry A; Jenkins R B; Dahl R J; Moertel C A; Scheithauer B W
Cytogenetic analysis of aggressive meningiomas: possible diagnostic and prognostic implications.
Cancer 1996;77(12):2567-73.
1996: Persons D L; Robinson R A; Hsu P H; Seelig S A; Borell T J; Hartmann L C; Jenkins R B
Chromosome-specific aneusomy in carcinoma of the breast.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):883-8.
1996: Takahashi S; Alcaraz A; Brown J A; Borell T J; Herath J F; Bergstralh E J; Lieber M M; Jenkins R B
Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):137-45.
1996: Qian J; Jenkins R B; Bostwick D G
Potential markers of aggressiveness in prostatic intraepithelial neoplasia detected by fluorescence in situ hybridization.
European urology 1996;30(2):177-84.
1995: Qian J; Bostwick D G; Takahashi S; Borell T J; Herath J F; Lieber M M; Jenkins R B
Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.
Cancer research 1995;55(22):5408-14.
1995: Takahashi S; Jenkins R B; Lieber M M
Cytogenetic analysis of prostate carcinoma by fluorescence in situ hybridization.
International journal of urology : official journal of the Japanese Urological Association 1995;2(4):215-23.
1995: Takahashi S; Shan A L; Ritland S R; Delacey K A; Bostwick D G; Lieber M M; Thibodeau S N; Jenkins R B
Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.
Cancer research 1995;55(18):4114-9.
1995: Lindor N M; Karnes P S; Michels V V; Dewald G W; Goerss J; Jalal S; Jenkins R B; Vockley G; Thibodeau S N
Uniparental disomy in congenital disorders: a prospective study.
American journal of medical genetics 1995;58(2):143-6.
1995: Dalrymple S J; Herath J F; Ritland S R; Moertel C A; Jenkins R B
Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas.
Journal of neurosurgery 1995;83(2):316-23.
1995: Ritland S R; Ganju V; Jenkins R B
Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma.
Genes, chromosomes & cancer 1995;12(4):277-82.
1994: Dalrymple S J; Jenkins R B
Molecular genetics of astrocytomas and meningiomas.
Current opinion in neurology 1994;7(6):477-83.
1994: Persons D L; Hartmann L C; Herath J F; Keeney G L; Jenkins R B
Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors.
American journal of clinical pathology 1994;102(6):775-9.
1994: Brown J A; Alcaraz A; Takahashi S; Persons D L; Lieber M M; Jenkins R B
Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma.
The Journal of urology 1994;152(4):1157-62.
1994: Dalrymple S J; Herath J F; Borell T J; Moertel C A; Jenkins R B
Correlation of cytogenetic and fluorescence in situ hybridization (FISH) studies in normal and gliotic brain.
Journal of neuropathology and experimental neurology 1994;53(5):448-56.
1994: Ganju V; Jenkins R B; O'Fallon J R; Scheithauer B W; Ransom D T; Katzmann J A; Kimmel D W
Prognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers.
Cancer 1994;74(3):920-7.
1994: Witzig T E; Borell T J; Herath J F; Tefferi A; Li C Y; Jenkins R B
Detection of trisomy 12 by FISH in untreated B-chronic lymphocytic leukemia: correlation with stage and CD20 antigen expression intensity.
Leukemia & lymphoma 1994;14(5-6):447-51.
1994: Alcaraz A; Takahashi S; Brown J A; Herath J F; Bergstralh E J; Larson-Keller J J; Lieber M M; Jenkins R B
Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer.
Cancer research 1994;54(15):3998-4002.
1994: Persons D L; Takai K; Gibney D J; Katzmann J A; Lieber M M; Jenkins R B
Comparison of fluorescence in situ hybridization with flow cytometry and static image analysis in ploidy analysis of paraffin-embedded prostate adenocarcinoma.
Human pathology 1994;25(7):678-83.
1994: Takahashi S; Qian J; Brown J A; Alcaraz A; Bostwick D G; Lieber M M; Jenkins R B
Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
Cancer research 1994;54(13):3574-9.
1994: Dodson M K; Cliby W A; Xu H J; DeLacey K A; Hu S X; Keeney G L; Li J; Podratz K C; Jenkins R B; Benedict W F
Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
Cancer research 1994;54(3):610-3.
1994: Herath S E; Stalboerger P G; Dahl R J; Parisi J E; Jenkins R B
Cytogenetic studies of four hemangiopericytomas.
Cancer genetics and cytogenetics 1994;72(2):137-40.
1993: Jenkins R B; Bartelt D; Stalboerger P; Persons D; Dahl R J; Podratz K; Keeney G; Hartmann L
Cytogenetic studies of epithelial ovarian carcinoma.
Cancer genetics and cytogenetics 1993;71(1):76-86.
1993: Dodson M K; Hartmann L C; Cliby W A; DeLacey K A; Keeney G L; Ritland S R; Su J Q; Podratz K C; Jenkins R B
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Cancer research 1993;53(19):4456-60.
1993: Dewald G W; Schad C R; Christensen E R; Law M E; Zinsmeister A R; Stalboerger P G; Jalal S M; Ash R C; Jenkins R B
Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation.
Bone marrow transplantation 1993;12(2):149-54.
1993: Persons D L; Gibney D J; Katzmann J A; Lieber M M; Farrow G M; Jenkins R B
Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma.
The Journal of urology 1993;150(1):120-5.
1993: Cliby W; Sarkar G; Ritland S R; Hartmann L; Podratz K C; Jenkins R B
Absence of prohibitin gene mutations in human epithelial ovarian tumors.
Gynecologic oncology 1993;50(1):34-7.
1993: Moertel C A; Dahl R J; Stalboerger P G; Kimmel D W; Scheithauer B W; Jenkins R B
Gliosis specimens contain clonal cytogenetic abnormalities.
Cancer genetics and cytogenetics 1993;67(1):21-7.
1993: Cliby W; Ritland S; Hartmann L; Dodson M; Halling K C; Keeney G; Podratz K C; Jenkins R B
Human epithelial ovarian cancer allelotype.
Cancer research 1993;53(10 Suppl):2393-8.
1993: Persons D L; Hartmann L C; Herath J F; Borell T J; Cliby W A; Keeney G L; Jenkins R B
Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.
The American journal of pathology 1993;142(3):733-41.
1992: Ransom D T; Ritland S R; Kimmel D W; Moertel C A; Dahl R J; Scheithauer B W; Kelly P J; Jenkins R B
Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas.
Genes, chromosomes & cancer 1992;5(4):348-56.
1992: Lindor N M; Ney J A; Gaffey T A; Jenkins R B; Thibodeau S N; Dewald G W
A genetic review of complete and partial hydatidiform moles and nonmolar triploidy.
Mayo Clinic proceedings. Mayo Clinic 1992;67(8):791-9.
1992: Kraker W J; Borell T J; Schad C R; Pennington M J; Karnes P S; Dewald G W; Jenkins R B
Fluorescent in situ hybridization: use of whole chromosome paint probes to identify unbalanced chromosome translocations.
Mayo Clinic proceedings. Mayo Clinic 1992;67(7):658-62.
1992: Jenkins R B; Le Beau M M; Kraker W J; Borell T J; Stalboerger P G; Davis E M; Penland L; Fernald A; Espinosa R; Schaid D J
Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens.
Blood 1992;79(12):3307-15.
1992: Olopade O I; Jenkins R B; Ransom D T; Malik K; Pomykala H; Nobori T; Cowan J M; Rowley J D; Diaz M O
Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.
Cancer research 1992;52(9):2523-9.
1992: Pierotti M A; Santoro M; Jenkins R B; Sozzi G; Bongarzone I; Grieco M; Monzini N; Miozzo M; Herrmann M A; Fusco A
Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(5):1616-20.
1991: Herrmann M A; Hay I D; Bartelt D H; Ritland S R; Dahl R J; Grant C S; Jenkins R B
Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.
The Journal of clinical investigation 1991;88(5):1596-604.
1991: Herrmann M A; Hay I D; Bartelt D H; Spurbeck J L; Dahl R J; Grant C S; Jenkins R B
Cytogenetics of six follicular thyroid adenomas including a case report of an oxyphil variant with t(8;14)(q13;q24.1).
Cancer genetics and cytogenetics 1991;56(2):231-5.
1991: Schad C R; Kraker W J; Jalal S M; Tallman M S; Londer H N; Cook L P; Jenkins R B
Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disorders.
American journal of clinical pathology 1991;96(2):203-10.
1990: Jenkins R B; Hay I D; Herath J F; Schultz C G; Spurbeck J L; Grant C S; Goellner J R; Dewald G W
Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma.
Cancer 1990;66(6):1213-20.
1990: Hamann K J; Ten R M; Loegering D A; Jenkins R B; Heise M T; Schad C R; Pease L R; Gleich G J; Barker R L
Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily.
Genomics 1990;7(4):535-46.
1990: Dewald G W; Diez-Martin J L; Steffen S L; Jenkins R B; Stupca P J; Burgert E O
Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome.
American journal of medical genetics. Supplement 1990;7():247-50.
1989: Jenkins R B; Kimmel D W; Moertel C A; Schultz C G; Scheithauer B W; Kelly P J; Dewald G W
A cytogenetic study of 53 human gliomas.
Cancer genetics and cytogenetics 1989;39(2):253-79.
1989: Schwartz H S; Jenkins R B; Dahl R J; Dewald G W
Cytogenetic analyses on giant-cell tumors of bone.
Clinical orthopaedics and related research 1989;(240):250-60.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Robert Jenkins

Research Profile (preview)

Procedures

Disorders

Anatomy

Physiology

Concepts & Ideas

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Robert Jenkins (preview)

All Publications